Jackson Acquisition Co II JACS
company incorporated in the Cayman Islands on September 11, 2024, for the purpose of entering into a merger, share exchange, asset acquisition,
share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. While we may
pursue an initial business combination target in any industry or geographic location, we intend to focus our search for a target business
by concentrating our efforts in identifying high-quality businesses with a focus on healthcare services, healthcare technology, or otherwise
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| SG&A | $569.1K | — |
| Operating income | -$569.1K | — |
| Net income | $9.1M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Cash and equivalents | $521.8K | $949.4K |
| Total current assets | $633.1K | $1.1M |
| Total assets | $243.2M | $234.0M |
| Accounts payable | $87.3K | $57.6K |
| Total current liabilities | $412.3K | $357.5K |
| Retained earnings | $220.1K | $381.1K |
| Total equity | $220.8K | $789.9K |
Cash flow
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Operating cash flow | -$427.6K | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-032353.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2024 | FY2025 |
|---|---|---|
| Revenue | — | — |
| Gross profit | — | — |
| Net income | — | $9.1M |
Recent filings and events
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Annual report filed Form 10-K
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Other event Item 8.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Other event Item 8.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 6770
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| DMII | Drugs Made In America Acquisition II Corp. | $649.1M | — | — |
| IACO | Idea Acquisition Corp. | $437.9M | — | — |
| KRAQ | KRAKacquisition Corp | $430.8M | — | — |
| TACO | Berto Acquisition Corp. | $393.2M | 36.1x | — |
| ALDF | Aldel Financial II Inc. | $328.0M | — | — |
| ATII | Archimedes Tech SPAC Partners II Co. | $290.3M | — | — |
| FGII | FG Imperii Acquisition Corp. | $290.3M | — | — |
| SOUL | Soulpower Acquisition Corp. | $269.3M | — | — |